Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Galidesivir

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioCryst Provides Update on Galidesivir Program
    BioCryst Provides Update on Galidesivir Program

    22 Dec 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/12/22/2149264/0/en/BioCryst-Provides-Update-on-Galidesivir-Program.html

    GLOBENEWSWIRE
    22 Dec 2020
    Share Share
    BioCryst Provides Update on Galidesivir Program
    BioCryst Provides Update on Galidesivir Program

    22 Dec 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/12/22/2149264/0/en/BioCryst-Provides-Update-on-Galidesivir-Program.html

    GLOBENEWSWIRE
    22 Dec 2020
    Share Share
    Galidesivir Stops Zika Viral Replication in Primate Model
    Galidesivir Stops Zika Viral Replication in Primate Model

    10 Jun 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/06/10/2046454/0/en/Galidesivir-Stops-Zika-Viral-Replication-in-Primate-Model.html

    GLOBENEWSWIRE
    10 Jun 2020
    Share Share
    BioCryst Begins Clinical Trial with Galidesivir for COVID-19
    BioCryst Begins Clinical Trial with Galidesivir for COVID-19

    09 Apr 2020

    // YAHOO

    https://finance.yahoo.com/news/biocryst-begins-clinical-trial-galidesivir-204510318.html

    YAHOO
    09 Apr 2020
    Share Share
    Can old drugs take down a new coronavirus?
    Can old drugs take down a new coronavirus?

    13 Mar 2020

    // Lisa M. Jarvis C&EN

    https://cen.acs.org/sections/coronavirus/biological-chemistry/infectious-disease/coronavirus-drug-repurposing.html

    Lisa M. Jarvis C&EN
    13 Mar 2020
    Share Share
    BioCryst Completes Phase 1 Clinical Trial of Galidesivir
    BioCryst Completes Phase 1 Clinical Trial of Galidesivir

    09 May 2019

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2019/05/09/1821410/0/en/BioCryst-Completes-Phase-1-Clinical-Trial-of-Galidesivir.html

    GLOBENEWSWIRE
    09 May 2019
    Share Share